Clinical Effectiveness of Intervertebral Disc Release in Treating Lenke 5 Adolescent Idiopathic Scoliosis
Launched by PEKING UNION MEDICAL COLLEGE HOSPITAL · Feb 25, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new surgical technique called intervertebral disc release (IDR) to treat a specific type of scoliosis known as Lenke Type 5 adolescent idiopathic scoliosis (AIS). Scoliosis is a condition where the spine curves abnormally, and in this trial, researchers want to see if IDR can better correct the spine's rotation compared to a traditional method called Ponte osteotomy. The goal is to improve the patients' overall spinal alignment while minimizing complications like blood loss or longer hospital stays.
To participate in this study, individuals must be between the ages of 10 and 18 and have Lenke Type 5 AIS, without any previous spinal surgeries or certain other scoliosis conditions. Participants will be randomly assigned to receive either the IDR or the Ponte osteotomy. Throughout the trial, researchers will monitor how well each method corrects the spine's curvature, how much blood is lost during surgery, how long patients stay in the hospital, and any side effects that may occur. The insights gained from this study could help improve treatment options for young people with scoliosis.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Between the ages of 10 and 18
- • American Society of Anesthesiologists (ASA) physical statusclassification of I-II
- • Lenke 5 type adolescent idiopathic scoliosis
- Exclusion Criteria:
- • A history of previous corrective surgery
- • With sharp, angulated short-segmental scoliosis
- • With congenital scoliosis requiring 3-column osteotomy
About Peking Union Medical College Hospital
Peking Union Medical College Hospital (PUMCH) is a prestigious medical institution and a leading research facility located in Beijing, China. Affiliated with the Chinese Academy of Medical Sciences, PUMCH is renowned for its commitment to advancing healthcare through innovative clinical research and high-quality patient care. The hospital plays a pivotal role in the development and execution of clinical trials across various medical disciplines, focusing on improving treatment outcomes and enhancing medical knowledge. With a multidisciplinary team of experts and state-of-the-art facilities, PUMCH is dedicated to contributing to global health advancements and fostering collaborations in the medical research community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Beijing, , China
Beijing, Beijing, China
Patients applied
Trial Officials
Qianyu Zhuang, Professor
Principal Investigator
Peking Union Medical College Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported